We are live on ! Find out more
HHAA

Henry H. Armstrong Associates Portfolio holdings

AUM $1.03B
1-Year Est. Return 4.23%
This Fund
S&P 500
This Quarter Est. Return
+2.47%
1 Year Est. Return
+4.23%
3 Year Est. Return
+49.29%
5 Year Est. Return
+75.36%
10 Year Est. Return
+299.63%
AUM
$524M
AUM Growth
-$4.07M
Cap. Flow
-$14.7M
Cap. Flow %
-2.81%
Top 10 Hldgs %
87.76%
Holding
55
New
3
Increased
23
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.53M
2
PG icon
Procter & Gamble
PG
+$1.47M
3
AGN
Allergan plc
AGN
+$867K
4
INTC icon
Intel
INTC
+$824K
5
UNP icon
Union Pacific
UNP
+$788K

Top Sells

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$22.4M
2
AGN
Allergan Inc
AGN
+$882K
3
DIS icon
Walt Disney
DIS
+$832K
4
EXPD icon
Expeditors International
EXPD
+$77K
5
WU icon
Western Union
WU
+$30K

Sector Composition

Rank Sector Weight
1 Financials 39.27%
2 Healthcare 24.06%
3 Technology 18.89%
4 Consumer Staples 10.94%
5 Industrials 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COST icon
51
Costco
COST
$420B
$204K 0.04%
1,277
– –
CDNA icon
52
CareDx
CDNA
$2.44B
– –
-16,036
Closed -$22.4M
AGN
53
DELISTED
Allergan Inc
AGN
– –
-3,690
Closed -$882K
1 2
3

Similar funds

RIM
RW Investment Management Eagle, Idaho $1.03B AUM
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
CM
Condire Management Dallas, Texas $1.03B AUM 162.78% 1-Year Est. Return
CFFNO
Common Fund For Nonprofit Organizations Wilton, Connecticut $1.03B AUM 22.44% 1-Year Est. Return
TBA
Tower Bridge Advisors Conshohocken, Pennsylvania $1.04B AUM 23.66% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MSIIA
Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.04B AUM 22.76% 1-Year Est. Return

Henry H. Armstrong Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Henry H. Armstrong Associates held 55 positions worth $524M, down 0.77% from $528M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Henry H. Armstrong Associates's Q2 2017 filing shows 3 new, 23 increased, 6 reduced and 3 closed positions. Its largest new stake was Allergan plc: 3,690 shares worth $897K. The largest sale was CareDx, an estimated $22.4M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Healthcare and Technology.

  • Henry H. Armstrong Associates's largest Q2 2017 buy was Allergan plc: 3,690 shares worth $897K.
  • Henry H. Armstrong Associates added most to Medtronic in Q2 2017, an estimated $1.53M increase.
  • Henry H. Armstrong Associates's biggest Q2 2017 reduction was Walt Disney, cutting an estimated $832K.
  • Henry H. Armstrong Associates fully exited CareDx in Q2 2017, selling an estimated $22.4M.
  • Henry H. Armstrong Associates's ten largest holdings make up 88% of its $524M portfolio in Q2 2017.
  • Henry H. Armstrong Associates opened 3 new positions and closed 3 in Q2 2017.
  • Henry H. Armstrong Associates's portfolio value fell 0.77% quarter-over-quarter to $524M.

Based on Henry H. Armstrong Associates's 13F filing for Q2 2017, filed 26 Jul 2017.